JG

James Garner

Percheron Therapeutics Limited | Chief Executive Officer, Managing Director
Dr Garner brings broad experience in drug development and commercialisation, acquired through regional and global roles in the biotech and pharmaceutical sector. His previous responsibilities have included leading phase I-IV clinical trials, product registration, reimbursement, and business development.

Company and Roles

Company
Title
Tenure
Since
PER
PER
Percheron Therapeutics Limited
  • Chief Executive Officer
  • Managing Director
1yrs, 4mthMay 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PER
PER
Percheron Therapeutics Limited
30/06/241,000,000N/A6,690,000N/A
ANP
ANP
29/11/231,000,000N/A6,690,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ANP
ANP
29/11/23
Issued
6,690,000$0.060$401,400Issue of options
PER
PER
Percheron Therapeutics Limited
29/11/23
Issued
6,690,000$0.060$401,400Issue of options
ANP
ANP
17/11/23
Buy
100,000$0.061$6,100On-market trade
PER
PER
Percheron Therapeutics Limited
17/11/23
Buy
100,000$0.061$6,100On-market trade
ANP
ANP
22/08/23
Issued
600,000$0.050$30,000Participation in share purchase plan